Skip to main content
Caplight Logo









Synvect

Synvect

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.synvect.com/

Last Round

Seed

Mar 11, 2025

Total Funding Raised

$4.98M

Company Overview

Synvect is a biotechnology company that develops a platform using CRISPR technology to create sterile male mosquitoes for suppressing disease-transmitting vector populations.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Environmental Monitoring

Business Model

B2G

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Non-AI

Keywords

CRISPRsterile insect techniqueSITmosquito controlvector controlgene drivebiotechnologypest controlgenetically modified insectsgmo mosquitoesbiological pest controlpublic health technologydisease prevention

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synvect Comparables

Compare Synvect with similar companies based on industry and business-model similarity.

Synvect comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Diptera.ai
87%
Terratis
85%
Biocentis
84%

Synvect Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 11, 2025
GrantNov 21, 2024
Pre SeedSep 6, 2024
GrantAug 1, 2023

Key People

Founding team and executive leadership

Nikolay Kandul

Co-Founder & CEO

Founding Team

Synvect Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 11, 2025

    $3M raised in Seed round.

  • Nov 21, 2024

    $25K grant from Columbia University Tamer Fund.

Synvect Filings

Explore SEC and related filing metadata, where available.

Synvect filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Synvect's valuation, stock price, and market status.

Is Synvect a public or private company?

Synvect is a private company.

What is the current stock price of Synvect?

Synvect is a private company with no public stock price. No recent secondary market data is available.

How much is Synvect worth (valuation)?

Valuation information for Synvect is not publicly available.

Can I buy Synvect stock?

Synvect shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Synvect's last funding round?

Synvect's most recent funding round was Seed on March 11, 2025.

Who are the main investors in Synvect?

Key investors in Synvect include Redbud VC, Bill & Melinda Gates Foundation, The Bill & Melinda Gates Foundation Trust, Antler AI Disrupt, NuFund.

Will Synvect IPO soon?

No public IPO plans have been announced for Synvect.

How can I track Synvect secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Synvect's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range6
Year Founded2022
Last FundingMar 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?